NBGI Private Equity

NBGI Private Equity - Ventures

Sound judgement and commercial insight drawing on our own management experience in a wide variety of businesses.

News

12 August 2009

Reverse Medical Corporation Receives CE Mark Clearance for the ReStoreTM Microcatheter for Blood Flow Restoration in Acute Ischemic Stroke Patients

Reverse Medical Corporation announced today that it has received CE Mark (Conformité Européenne) for its ReStore™ Microcatheter, intended to restore blood flow in the neurovasculature in patients experiencing ischemic stroke.

16 June 2009

Upfront Chromatography licenses use of EBA technology to Cangene

Upfront Chromatography A/S, a leading developer of customised industrial-scale protein chromatography processes, has signed a licensing agreement with Cangene Corporation , a world leader in developing, manufacturing, and commercialising specialty hyperimmune plasma and biotechnology products.

02 June 2009

Estech completes additional $8 Million financing and names Tony Remington as US Vice President of Sales

New Financing to Support Continued Expansion of Sales, Marketing and Product Development

27 May 2009

SuperSonic Imagine concludes the extension of its second round of financing

SuperSonic Imagine announces the completion of a second round of fund-raising of €6 million with Wellington Partners and ICSO Private Equity. Edmond de Rothschild Investment Partners was the leader in this fund-raising round that started in October 2008 with a global amount of €26 million.

17 April 2009

20/10 Perfect Vision and Bausch & Lomb Finalize Refractive Surgery Joint Venture

20/10 Perfect Vision AG, the femtosecond laser developer, and Bausch & Lomb, the global eye health company, have completed their transaction to form a joint venture focused on the laser vision correction industry.